Prescriber Insights: APRN

Article: Atelvia (uh-TEL-vee-uh), a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis February 2011

Article: controversy over the Institute of Medicine's new recommendations (RDA) for vitamin D and calcium January 2011

Guideline: Dietary Reference Intakes for Calcium and Vitamin D (2011) January 2011

Article: new concerns that bisphosphonates might increase the risk of esophageal cancer and femur fractures October 2010

Other: FDA Podcast: Bisphosphonates and Risk of Esophageal Cancer (July 2011) October 2010

Commentary: Bisphosphonates: Esophageal Cancer and Other Safety Concerns October 2010

Article: whether calcium supplements cause heart attacks September 2010

Commentary: New Drug: Prolia (Denosumab) August 2010

Guideline: Diagnosis and Treatment of Osteoporosis (ICSI) (Updated July 2013) August 2010

Guideline: Prevention and Treatment of Osteoporosis (NOF) (2013) August 2010

Article: new injectable monoclonal antibody for osteoporosis called Prolia (PRO-lee-a, denosumab) August 2010

Guideline: Management of Osteoporosis in Postmenopausal Women (NAMS) (2010) August 2010

Article: how much vitamin D is too much July 2010

Article: oral bisphosphonates (Fosamax, etc) might decrease the risk of breast cancer January 2010

Article: how long women should take a bisphosphonate for osteoporosis December 2009